Abstract

BackgroundRA related foot problems can be managed by providing custom made foot orthoses (FO). A recent systematic review showed FO to be effective in reducing pain and high plantar forefoot...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
In-shoe plantar pressure measurements for the evaluation and adaptation of foot orthoses in patients with rheumatoid arthritis: A proof of concept study
Menno Steenbergen ... Dirkjan Van Schaardenburg
Gait & Posture | VOL. 45
Menno Steenbergen, et. al.Menno Steenbergen ... Dirkjan Van Schaardenburg
29 Dec 2015
Efficacy of Multilayered Hosiery in Reducing In-Shoe Plantar Foot Pressure in High-Risk Patients With Diabetes
Andrew J.M Boulton ... Carine H.M Van Schie
Diabetes Care | VOL. 28
Andrew J.M Boulton, et. al.Andrew J.M Boulton ... Carine H.M Van Schie
25 Jul 2005
Evaluation of novel plantar pressure-based 3-dimensional printed accommodative insoles - A feasibility study
Brittney C Muir ... Yuri F Hudak
Clinical Biomechanics | VOL. 98
Brittney C Muir, et. al.Brittney C Muir ... Yuri F Hudak
01 Aug 2022
Characterization of postural stability in a simulated environment of an earthquake using in-shoe plantar pressure measurement
Z.O Abu-Faraj ... H.A Khalifeh
-
Z.O Abu-Faraj, et. al.Z.O Abu-Faraj ... H.A Khalifeh
01 Sep 2009
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers